Researchers Use Cancer Cells' Carbon Monoxide to Produce Anticancer Drug

Researchers at the RIKEN Pioneering Research Institute in Japan have developed a method to harness carbon monoxide produced by cancer cells to create drugs that target and destroy tumor cells from within. This approach represents a novel strategy in anticancer drug development by utilizing a cancer's own byproduct.

Originally published by gnews